Login

Delisting Not on the Agenda" | Francis Van Eeckhout (Deceuninck) | CEO Talk | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
RACHEL BOTSMAN ABOUT CREATING TRUST IN THE INTERNET ERA | Rachel Botsman, CEO, AEON CO (M) Bhd
00:00:00
Harry Fleming, CEO, Nobilis Health Corp
00:10:00
Novak Djokovic Launches PTPA to Empower Tennis Players Worldwide and Shapes Future of the Sport|Novak Djokovic,Serbian professional tennis player
00:10:00
Retirement Planning Masterclass: Greenberg Financial Group's Key Strategies | Dean Greenberg, Founder and Financial Advisor at Greenberg Financial Group
00:10:00
(JH2T 2024 - Dijon: Jan-Erik Starlander - France Hydrogène)
00:10:00
Delivering Low-Cost Energy and Addressing National Security | Rhett Bennett, CEO, Black Mountain Energy Ltd.
00:10:00
Advancing Cannabinoid Research and Market Expansion| Aras Azadian, CEO, Avicanna Inc.
00:10:00
Cofinimmo focuses on leveraging its financial stability| Jean-Pierre Hanin, CEO, Cofinimmo SA.
00:10:00
The Art and Science of Investing: Insights from PFM Asset Management's Alex Gurvich on the Dakota Live! Podcast
00:10:00
Reviving Yukon's Brewery Creek Gold Project: Insights from 121 Mining Investment Conference
00:10:00
Breaking down stigmas and biases in venture capital affecting female founders|Jesse Draper,General Partner,Halogen Ventures
00:10:00
Dr Romesh's Journey: From Bombay to Building Success in the U.S. | Dr Romesh Wadhwani, Co-Founder, Symphony Technology Group.

© 2026 Nehu